Whole Exome Sequencing Market Industry Size, Share Trends, Growth, Demand, Opportunities and Forecast By 2029
The significant Whole Exome Sequencing market report is prepared by a team of multilingual researchers who are skilled at different languages and hence perform market research internationally. Transparency in research method and use of excellent tools and techniques makes this market research report an outstanding. This market survey report is all-inclusive of the data which includes market definition, classifications, applications, engagements, market drivers and market restraints that are derived from SWOT analysis. Clients can experience a nice combination of best industry insight, practical solutions, talent solutions and latest technology while utilizing or applying such winning Whole Exome Sequencing report for the business growth.
Whole Exome Sequencing market research report contains a comprehensive data of market definition, classifications, applications, engagements, market drivers and market restraints all of which obtained from SWOT analysis. Analysis and discussion of important industry trends, market size, sales volume, and market share are also estimated in this market report. This business report gives an actionable market insight to the clients with which sustainable and profitable business strategies can be created. The large scale Whole Exome Sequencing report not only saves valuable time but also adds credibility to the work that has been done to grow the business.
Get the PDF Sample Copy (Including FULL TOC, Graphs and Tables) of this report @
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-whole-exome-sequencing-market
Global whole exome sequencing market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 19.0% in the forecast period of 2022 to 2029. The increase in healthcare expenditure and funding are the major drivers which propelled the demand of the market in the forecast period.
However, side effects associated with the treatments of whole exome sequencing may hamper the future growth of whole exome sequencing market. Adoption of strategic alliances like partnerships and acquisitions by key market players act as an opportunity for the growth of whole exome sequencing market.
Whole exome is a genomic technique for sequencing all of the protein-coding region of genes in a genome. Whole exome sequencing is available to patients who are searching for a unifying diagnosis for multiple medical conditions. A laboratory process that is used to determine the nucleotide sequence primarily of the exonic (or protein-coding) regions of an individual’s genome and related sequences, representing approximately 1% of the complete DNA sequence, also called WES. Whole-exome sequencing is a widely used whole exome sequencing method that involves sequencing the protein-coding regions of the genome. The human exome represents less than 2% of the genome, but contains ~85% of known disease-related variants, making this method a cost-effective alternative to whole-genome sequencing.
Exome sequencing using exome enrichment can efficiently detect coding variants across a wide range of applications, including population genetics, genetic disease and cancer studies. The growth of the global whole exome sequencing market is attributed to the reduction in time and cost for sequencing. With the development of new technologies and cancer cure treatment, the whole exome sequencing market in clinical oncology has huge potential in the coming years.
Access Full 350 Pages PDF Report @
Whole Exome Sequencing Market Dynamics
Drivers
- Increase in the adoption of next generation sequencing
As genomics-focused pharmacology continues to play a greater role in the treatment of various chronic diseases especially cancer, next-generation sequencing (NGS) is evolving as a powerful tool for providing a deeper and more precise insight at molecular underpinnings of individual tumours and specific receptors.
NGS offers advantages in accuracy, sensitivity and speed compared to traditional methods that have the potential to make a significant impact on the field of oncology. Because NGS can assess multiple genes in a single assay, the need to order multiple tests to identify the causative mutation is eliminated.
- Growing usage of targeted sequencing methods
As genomics-focused pharmacology continues to play a greater role in the treatment of various chronic diseases especially cancer, next-generation sequencing (NGS) is evolving as a powerful tool for providing a deeper and more precise insight at molecular underpinnings of individual tumours and specific receptors.
NGS offers advantages in accuracy, sensitivity and speed compared to traditional methods that have the potential to make a significant impact on the field of oncology. Because NGS can assess multiple genes in a single assay, the need to order multiple tests to identify the causative mutation is eliminated.
Restraint
- Less comprehensive coverage of exons
All the exons are not comprehensively captured. The exon of importance may not be included in the current standard annotations of the human genome; and it is merely arduous to cover 100% of the exome with the current WES technology. Consequently, disease-causing variants in these “missed” exons go undetected.
WES has low sensitivity for structural variations, hence detection is limited. Nonetheless some CNVs, including indels and duplications, can be detected by WES, the technical limitation implies that others are likely missed
The major companies which are dealing in the whole exome sequencing market are Thermo Fisher Scientific Inc., QIAGEN, Illumina, Inc., Beckman Coulter, Inc., Eurofins Scientific, BIONEER CORPORATION, ExoDx (a part of Bio-Techne), FOUNDATION MEDICINE, INC. (A subsidiary of F. Hoffmann-La Roche Ltd), GeneFirst Limited, CeGaT GmbH, Meridian, Merck KGaA, SOPHiA GENETICS, Azenta U.S. Inc., CD Genomics, Twist Bioscience, PerkinElmer Genomics (A Subsidiary of PerkinElmer Inc.), GeneDx, LLC, Psomagen, Integrated DNA Technologies, Inc., among others.
Table of Content:
Part 01: Executive Summary
Part 02: Scope of the Report
Part 03: Global Whole Exome Sequencing Market Landscape
Part 04: Global Whole Exome Sequencing Market Sizing
Part 05: Global Whole Exome Sequencing Market by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
For More Insights Get Detailed TOC @
Reasons to Buy:
- Review the scope of the Whole Exome Sequencing Market with recent trends and SWOT analysis.
- Outline of market dynamics coupled with market growth effects in coming years.
- Whole Exome Sequencing Market segmentation analysis includes qualitative and quantitative research, including the impact of economic and non-economic aspects.
- Regional and country level analysis combining Whole Exome Sequencing Market and supply forces that are affecting the growth of the market.
- Market value data (millions of US dollars) and volume (millions of units) for each segment and sub-segment.
- and strategies adopted by the players in the last five years.
Browse Trending Reports:
Global Dental Syringes Market Size, Share and Opportunities https://www.databridgemarketresearch.com/reports/global dental syringes market
Global Membrane Chromatography Market Size, Share and Opportunities https://www.databridgemarketresearch.com/reports/global membrane chromatography market
Global Dental Endodontics Market Size, Share and Opportunities https://www.databridgemarketresearch.com/reports/global dental endodontics market
Global Dental Microsurgery Market Size, Share and Opportunities https://www.databridgemarketresearch.com/reports/global dental microsurgery market
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Comments
Post a Comment